Consolidated Condensed Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 22,974	$ 15,558	$ 42,773	$ 28,286
Costs, expenses, and other:
Cost of sales	3,268	2,448	6,845	4,672
Research and development	3,819	3,336	7,329	6,070
Marketing, selling, and administrative	3,430	2,753	6,364	5,221
Acquired in-process research and development	2,776	154	3,360	1,726
Asset impairment, restructuring, and other special charges	703	0	982	35
Other–net, (income) expense	(269)	90	(204)	329
Costs, expenses, and other	13,727	8,781	24,676	18,053
Income before income taxes	9,247	6,777	18,097	10,233
Income taxes	2,152	1,116	3,606	1,813
Net income	$ 7,095	$ 5,661	$ 14,491	$ 8,420
Earnings per share:
Basic (in dollars per share)	$ 7.95	$ 6.30	$ 16.22	$ 9.37
Diluted (in dollars per share)	$ 7.94	$ 6.29	$ 16.19	$ 9.35
Shares used in calculation of earnings per share:
Basic (in shares)	892.4	897.9	893.5	898.3
Diluted (in shares)	893.7	899.8	894.8	900.2

Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net income	$ 14,491	$ 8,420
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:
Depreciation and amortization	1,043	941
Change in deferred income taxes	(433)	(1,460)
Stock-based compensation expense	362	339
Acquired in-process research and development	3,360	1,726
Other changes in operating assets and liabilities, net of acquisitions and divestitures	(2,334)	(5,627)
Other operating activities, net	(466)	414
Net Cash Provided by Operating Activities	16,023	4,753
Cash Flows from Investing Activities
Purchases of property and equipment	(5,259)	(3,207)
Purchases of noncurrent investments	(604)	(368)
Purchases of in-process research and development	(3,486)	(1,864)
Cash paid for acquisitions, net of cash acquired	(9,805)	0
Other investing activities, net	(158)	252
Net Cash Used for Investing Activities	(19,312)	(5,187)
Cash Flows from Financing Activities
Dividends paid	(3,094)	(2,693)
Net change in short-term borrowings	5,284	(246)
Proceeds from issuance of long-term debt	8,941	6,461
Repayments of long-term debt	(1,623)	(778)
Purchases of common stock	(3,957)	(1,892)
Other financing activities, net	(595)	(717)
Net Cash Provided by Financing Activities	4,956	135
Effect of exchange rate changes on cash and cash equivalents	15	407
Net increase in cash and cash equivalents	1,682	108
Cash and cash equivalents at January 1	7,268	3,268
Cash and Cash Equivalents at June 30	$ 8,950	$ 3,376

Consolidated Condensed Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 8,950	$ 7,268
Accounts receivable	20,083	17,760
Other receivables	3,392	2,395
Inventories	16,793	13,744
Prepaid expenses	15,368	14,315
Other current assets	86	147
Total current assets	64,672	55,629
Noncurrent Assets
Investments	3,856	2,802
Goodwill	8,849	5,898
Other intangibles, net	18,110	6,521
Deferred tax assets	10,028	9,959
Property and equipment, net of accumulated depreciation of $13,103 (2026) and $12,560 (2025)	29,286	24,675
Other noncurrent assets	7,482	6,992
Total assets	142,283	112,476
Current Liabilities
Short-term borrowings and current maturities of long-term debt	7,050	1,635
Accounts payable	6,112	5,379
Employee compensation	1,798	2,375
Sales rebates and discounts	21,122	17,382
Other current liabilities	11,659	8,457
Total current liabilities	47,741	35,228
Noncurrent Liabilities
Long-term debt	47,858	40,868
Long-term income taxes payable	5,461	5,875
Other noncurrent liabilities	7,344	3,970
Total noncurrent liabilities	60,663	50,713
Commitments and Contingencies
Equity
Common stock	588	590
Additional paid-in capital	7,117	7,346
Retained earnings	31,893	24,470
Employee benefit trust	(3,013)	(3,013)
Accumulated other comprehensive loss	(2,761)	(2,880)
Other equity	55	22
Total equity	33,879	26,535
Total liabilities and equity	$ 142,283	$ 112,476